Real-world availability of CAR T-cell therapies
Blood Podcast editor Laurie Sehn interviews Dr. Edward Cliff about his research on the global availability of CAR T-cell therapies. The study examines health technology assessment across G20 countries, highlighting disparities in access to FDA-approved products and indications.